The FDA last week notified Moderna that the agency would not review its application for a new mRNA flu vaccine, citing the company’s failure to perform an “adequate and well-controlled” clinical trial...

The Congressional Budget Office’s (CBO’s) recently issued report, The Budget and Economic Outlook: 2026 to 2036, offers a sobering look...